Hepatitis B and pregnancy

Current Hepatitis Reports

Volumn 8, Issue 3, 2009, Pages 91-95

  Tran, Tram T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ENTECAVIR; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PLACEBO; TELBIVUDINE; TENOFOVIR; VIRUS DNA; VIRUS RNA;

ABSENCE OF SIDE EFFECTS; ACTIVE IMMUNIZATION; AMNIOCENTESIS; ANTIVIRAL THERAPY; BIRTH DEFECT; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FETOTOXICITY; FIRST TRIMESTER PREGNANCY; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION RISK; INTRAUTERINE INFECTION; LOW BIRTH WEIGHT; PASSIVE IMMUNIZATION; PERINATAL INFECTION; PLACENTAL TRANSFER; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURITY; REVIEW; RISK ASSESSMENT; TREATMENT DURATION; VERTICAL TRANSMISSION; VIREMIA; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 68349096171     PISSN: 15403416     EISSN: 15410706     Source Type: Journal    
DOI: 10.1007/s11901-009-0013-y     Document Type: Review

References (36)

1. World Health Organization: Hepatitis B. World Health Organization fact sheet 204 (revised October 2000). Available at http://who.int/inf-fs/en/ fact204.html. Accessed March 2009.
2. Coleman PJ, McQuillan Gm, Moyer LA, et al.: Incidence of hepatitis B virus infection in the United States-implications for vaccination strategies. J Infect Dis 1988, 178: 1579-1584.
3. MargoliE HS, Alter MJ, Hadler SC: Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991, 11: 84-92.
4. Connolly JH, McClelland WM, O'Neill HJ, et al.: Hepatitis B virus infection in Northern Ireland 1970-1987. Ulster Med J 1989, 58: 72-82.
5. Stevens CE, Beasley RP, Tsui J, et al.: Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975, 292: 771-774.
6. Xu ZY, Duan SC, Margolis HS, et al.: Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B. J Infect Dis 1995, 171: 54-60.
7. Ngui SL, O'Connell S, Eglin RP, et al.: Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis 1997, 176: 1360-1365.
8. Lee SD, Lo KJ, Tsai YT, et al.: Maternal hepatitis B virus DNA in mother-infant transmission. Lancet 1989, 1: 719.
9. Karthigesu VD, Allison LM, Ferguson M, et al.: A hepatitis B virus variant found in the sera of immunised children induces a conformational change in the HBsAg "a" determinant. J Med Virol 1999, 58: 346-352.
10. Sookoian S: Effect of pregnancy on pre-existiCg liver disease: chronic viral hepatitis. Ann Hepatol 2006, 5: 190-197.
11. Ornoy A, Tenebaum A: Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio, and encephalitis virus. Repro Toxic 2006, 21: 446-457.
12. ter Borg MJ, Leemans WF, de Man RA, Janssen HLA: Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepat 2008, 15: 37-41.
13. Lin HH, Lee TY, Chen DS, et al.: Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987, 111: 877-881.
14. Lazizi Y, Badur S, Perk Y: Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA. Vaccine 1997, 15: 1095-1100.
15. Gerety RJ: Maternal transmission of hepatitis B [letter]. N Engl J Med 1976, 295: 170-171.
16. Chircu LV, Mattiaccu M, Schiano G, et al.: HBs and anti-HBs survey in mother/infant pairs [letter]. Lancet 1975, 2: 706.
17. Xu DZ, Yan YP, Choi BC, et al.: Risk factors and mechanism of transplacental transmission of hepatitis B virus: A case-control study. J Med Virol 2002, 67: 20-26.
18. Lin HH, Lee TY, Chen DS, et al.: Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987, 111: 877-881.
19. Towers CV, Asrat T, Rumney P: The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol 2001, 184: 1514-1518.
20. Burk RD, Hwang LY, Ho GY, et al.: Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994, 170: 1418-1423.
21. Lee SD, Lo KJ, Tsai YT, et al.: Role of Caesarean section in prevention of mother-infant transmission of hepatitis B. Lancet 1988, 2: 833-834.
22. Pao CC, Yao DS, Lin MY, et al.: Hepatitis B virus DNA in cervicovaginal cells. Arch Pathol Lab Med 1991, 115: 607-609.
23. Zhang SL, Yue YF, Bai GQ, et al.: Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 2004, 10: 437-438.
24. Wang J, Zhu Q, Zhang X: Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chinese Med J 2002, 115: 1510-1512.
25. Marion SA, Pastore MT, Pi DW, et al.: Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol 1994, 140: 734-736.
26. AnPre FE, Zuckerman AJ: Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994, 44: 144-151.
27. Hill JB, Sheffield JS, Kim MJ, et al.: Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002, 99: 1049-1052.
28. Mast EE, Margolis HS, Fiore AE, et al.; Advisory Committee on Immunization Practices (ACIP): A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: Immunization of infants, children, and adolescents. MMWR Recomm Rep 2005, 54(RR-16): 1-31.
29. Mast E, Mahoney F, Kane M, et al.: Hepatitis B vaccine. In Vaccines. Edited by Plotkin SA, Orenstein WA. Philadelphia: Saunders; 2004:299-337.
30. Wiseman E, Fraser MA, Holden S, et al.: Perinatal transmission of hepatitis B virus: An Australian experience. Med J Aust 2009, 190: 489-492.
31. Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994, 331: 1173-1180.
32. van Zonneveld M, van Nunen AB, Niesters HG, et al.: Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003, 10: 294-297.
33. Xu WM, Cui YT, Wang L, et al.: Efficacy and safety of lamivudine in late pregnancy for the prevention of mother-child transmission of hepatitis B: A multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009, 16: 94-103.
34. Antiretroviral Pregnancy Registry Steering Committee: Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2008. Wilmington, NC: Registry Coordinating Center; 2008. Available at http://www.apregistry.com/forms/exec-summary.pdf. Accessed December 21, 2008.
35. Lok ASF, McMahon BJ: Chronic hepatitis B. Hepatology 2007, 45: 507-539.
36. Keeffe EB, Dieterich DT, Han SB, et al.: A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006, 4: 936-962.